US 11780839
Compounds for treating Huntington's disease
granted A61PA61P25/28
Quick answer
US patent 11780839 (Compounds for treating Huntington's disease) held by PTC THERAPEUTICS, INC. expires Mon Oct 05 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- PTC THERAPEUTICS, INC.
- Grant date
- Tue Oct 10 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Oct 05 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 12
- CPC classes
- A61P, A61P25/28